About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 672 record(s)
Req # A-2021-001664
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_04553348, E2B_02843633, 968020, 967704, 968013, 970085, 968150, 968156, 968232, 968246, 970164, 968660, 968447, 970430.Organization: Health Canada
February 2023
Req # A-2021-001881
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-105095-605.Organization: Health Canada
February 2023
Req # A-2021-002021
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-122113-875.Organization: Health Canada
February 2023
Req # A-2021-002033
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-100947-72.Organization: Health Canada
February 2023
Req # A-2022-000016
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-101391-582, Evaluation of the National COVID-19 Exposure Notification App.Organization: Health Canada
February 2023
Req # A-2022-000435
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-104284-48.Organization: Health Canada
February 2023
Req # A-2022-000471
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-105985-788, Deputy Ministerial Meeting with the Health Research Foundation.Organization: Health Canada
February 2023
Req # A-2022-000646
Adverse Drug Reactions (ADRs). Report numbers: E2B_05139181, E2B_05139899, E2B_05142130, E2B_05152571, E2B_05160038, E2B_05173389, E2B_05174363, E2B_05183134, E2B_05196120, E2B_05203124.Organization: Health Canada
February 2023
Req # A-2022-000677
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-107558-330, Deputy Ministerial Meeting with the Patented Medicine Prices Review Board.Organization: Health Canada
February 2023
Req # A-2022-000708
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-106786-163.Organization: Health Canada
February 2023